Adherence to 2016 European Society of Cardiology guidelines predicts outcome in a large real-world population of heart failure patients requiring cardiac resynchronization therapy.

[1]  A. Auricchio,et al.  20 years of cardiac resynchronization therapy. , 2014, Journal of the American College of Cardiology.

[2]  A. Epstein,et al.  Large clinical trials in the management of ventricular arrhythmias. Applying group results to individual cases. , 2000, Cardiology clinics.

[3]  S. Solomon,et al.  Predictors of Response to Cardiac Resynchronization Therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) , 2011, Circulation.

[4]  Kenneth Ellenbogen,et al.  Cardiac resynchronization therapy (CRT): clinical trials, guidelines, and target populations. , 2012, Heart rhythm.

[5]  M. Packer,et al.  Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. , 2001, Journal of cardiac failure.

[6]  J. Cox,et al.  Use of Primary Prevention Implantable Cardioverter-Defibrillators in a Population-Based Cohort Is Associated With a Significant Survival Benefit , 2012, Circulation. Arrhythmia and electrophysiology.

[7]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[8]  R. Redberg,et al.  Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. , 2008, Archives of internal medicine.

[9]  Finn Gustafsson,et al.  2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[10]  John L Sapp,et al.  Cardiac-resynchronization therapy for mild-to-moderate heart failure. , 2010, The New England journal of medicine.

[11]  C. Leclercq,et al.  Avoiding non-responders to cardiac resynchronization therapy: a practical guide , 2016, European heart journal.

[12]  D. Julian.  What is Right and What is Wrong About Evidence‐Based Medicine? , 2003, Journal of cardiovascular electrophysiology.

[13]  Wojciech Zareba,et al.  Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.

[14]  M. Drazner,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[15]  G. Mascioli,et al.  Cardiac Resynchronization Therapy MOdular REgistry: ECG and Rx predictors of response to cardiac resynchronization therapy (NCT01573091) , 2013, Journal of cardiovascular medicine.

[16]  Ritu Sharma,et al.  Predictors of response to cardiac resynchronization therapy: A systematic review. , 2016, International journal of cardiology.